SCHEMBL11304997

SCHEMBL11304997

O=C(NO)c1ccc(N(c2cccc3[nH]c(=O)ccc23)C2CCNC2)cc1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 8/20 0.33
▸ HDAC1 Q13547 6/20 0.33
▸ ALOX15 P16050 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ ALOX12 P18054 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ ADAM17 P78536 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SLC6A2 P23975 5/20 0.32
▸ SLC6A4 P31645 5/20 0.32
▸ SLC6A3 Q01959 4/20 0.32
▸ HDAC8 Q9BY41 1/20 0.32
▸ HDAC11 Q96DB2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ KCNH2 Q12809 1/20 0.31
▸ ENPP1 P22413 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11301418 0.84 SLC6A4 (0.39) HDAC6ALOX15KDM4EMEN1LMNA
SCHEMBL11306334 0.77 HDAC1 (0.45) HDAC6HDAC1ALOX15KDM4EMEN1
SCHEMBL11294789 0.76 BRD4 (0.50) SLC6A2SLC6A4
SCHEMBL11298741 0.75 SLC6A4 (0.45) SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL11301824 0.74 KDM4E (0.39) HDAC6HDAC1ALOX15KDM4EMEN1
SCHEMBL11300763 0.74 HDAC8 (0.42) ALOX15KDM4EMEN1LMNAALOX12
SCHEMBL11304366 0.72 SLC6A2 (0.44) SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL11299962 0.72 SLC6A4 (0.39) KDM4EMEN1KMT2ASLC6A2SLC6A4
SCHEMBL11294920 0.70 KDR (0.39) HDAC6SLC6A2SLC6A4SLC6A3HDAC8
SCHEMBL11302583 0.68 SLC6A2 (0.53) HDAC6HDAC1ALOX15KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback